Cadila Pharma to invest Rs 1000 Cr in different ongoing projects

22 March 2023 | News

Creating direct and indirect employment for people by 2025

Ahmedabad-based Cadila Pharmaceuticals has signed a Memorandum of Understanding (MoU) with the government of Gujarat to invest Rs 1,000 crore in different existing projects.

The MoU was signed in Gandhinagar between Industries Commissioner Rahul Gupta on behalf of the government of Gujarat and Cadila Pharmaceuticals COO, Mitul Dave, under the Government of Gujarat’s “Atma Nirbhar Gujarat Schemes for Assistance to Industries”.

"Gujarat is the most preferred investment destination because of its conducive business environment, ease of doing business, and investor-friendly policies. Cadila Pharmaceuticals is in expansion mode and therefore investing to upgrade its existing facilities to meet emerging demands,” said Dr Rajiv Modi, Chairman & Managing Director of Cadila Pharmaceuticals.

The company will overall invest Rs 1000 crore in a span of three years until 2025 for setting up an Active Pharmaceuticals Ingredients (APIs) plant at Dahej, Bharuch & Ankleshwar and the Formation of Tablet & Capsules at Dholka Dist. Plant.

As proposed, these plants will create direct and indirect employment for around 500 people (direct) and 1000 (indirect) respectively by 2025.

As per the MoU, the Government of Gujarat will facilitate Cadila Pharmaceuticals to obtain necessary permissions, registrations, approvals and clearances from the concerned departments as per its existing policies and regulations.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account